Medisynth Dermoline Plus Cream is indicated for atopic dermatitis, eczema, pruritus, skin rashes, dry and cracked skin.
Medisynth Ch. Pvt. Ltd emphasis on the quality and efficacy of products has made one of the leading manufacturers of Homoeopathic Medicines in India . The company follows stringent standards of current Good Manufacturing Practice (cGMP) and is Winners of 5 National Awards.
Medisynth Dermoline Plus Cream Contains
Calendula Officinalis: Calendula Officinalis has antiseptic, antibacterial and antiviral properties, making it useful for salves and balms for cuts, wounds and for healing piercings. Any other lacerations, hang nails, bedsores, irritated rashes will benefit from using calendula. Calendula has been shown to work in the prevention of acute dermatitis for patients undergoing postoperative irradiation for breast cancer. To use for protection from environmental stressors, apply a calendula salve before and after the stress. Harness the uses of calendula for skin by making your own salve. Perhaps the most common and therapeutic uses of calendula for skin is for healing wounds. It is used on both new and old wounds, is safe for mucous membranes and has a great track record. It helps to heal burns (including sunburn), bruises and inflammatory diseases of the skin. Calendula is an emollient and can help to moisturize dry skin. It also contains carotenoids which nourish the skin.
Application: Apply Medisynth Dermoline Plus Cream locally two times a day or as prescribed by the physician.
Presentation: 20 gms
Manufacturer: Medisynth Ch. Pvt. Ltd
RATE/PRICE: Rs.95 (Buy Online!! Get 10% OFF)
Outside India? Shop Here. We ship to US, UK and all other countries worldwide through expedited international shipping
You can also conveniently order Medisynth Dermoline Plus Cream online by Mail, Phone or Whatsapp (#9686858499)
Online Order Form
If you have any question about Medisynth Dermoline Plus Cream or want advise on a medical condition requiring homeopathic treatment, please leave your comment below (in the comments section) and we will respond